Andrew E. Singer, EVP & CFO at Epizyme, Inc. (EPZM), sold 3,024 shares at $15.50 ($47K) on 2017-06-30, disclosed to the SEC on 2017-07-05.
Scheduled sale ($47k) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EPZM | SELL | 2016-12-12 | $11K | — | Filing → |
| EPZM | SELL | 2016-11-10 | $11K | — | Filing → |
| EPZM | SELL | 2016-10-12 | $20K | — | Filing → |